BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 12465750)

  • 1. Chemoprevention of prostate cancer.
    Kucuk O
    Cancer Metastasis Rev; 2002; 21(2):111-24. PubMed ID: 12465750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemoprevention of prostate cancer].
    Djavan B; Thompson I; Michel MS; Waldert M; Seitz C
    Urologe A; 2004 May; 43(5):557-61. PubMed ID: 15042290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
    Fujimoto N; Chang C; Nomura M; Matsumoto T
    Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
    Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
    Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer chemoprevention.
    Sandhu GS; Nepple KG; Tanagho YS; Andriole GL
    Semin Oncol; 2013 Jun; 40(3):276-85. PubMed ID: 23806493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic prevention studies of prostate cancer.
    Djavan B; Zlotta A; Schulman C; Teillac P; Iversen P; Boccon Gibod L; Bartsch G; Marberger M
    J Urol; 2004 Feb; 171(2 Pt 2):S10-3; discussion S13-4. PubMed ID: 14713746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
    Pathak SK; Sharma RA; Mellon JK
    Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.
    Kelloff GJ; Lieberman R; Steele VE; Boone CW; Lubet RA; Kopelovich L; Malone WA; Crowell JA; Higley HR; Sigman CC
    Urology; 2001 Apr; 57(4 Suppl 1):46-51. PubMed ID: 11295594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of prostate cancer: current status and future directions.
    Lieberman R
    Cancer Metastasis Rev; 2002; 21(3-4):297-309. PubMed ID: 12549768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of prostate cancer prevention.
    Brawley OW; Barnes S; Parnes H
    Ann N Y Acad Sci; 2001 Dec; 952():145-52. PubMed ID: 11795434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent approaches in chemoprevention of prostate cancer.
    Young CY
    Curr Cancer Drug Targets; 2007 Nov; 7(7):681-8. PubMed ID: 18045073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in prostate cancer chemoprevention: a translational perspective.
    Nambiar D; Singh RP
    Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio.
    Parnes HL; House MG; Kagan J; Kausal DJ; Lieberman R
    J Urol; 2004 Feb; 171(2 Pt 2):S68-74; discussion S75. PubMed ID: 14713758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development.
    Lieberman R
    Urology; 2001 Aug; 58(2 Suppl 1):83-90. PubMed ID: 11502457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications.
    Chhabra G; Singh CK; Ndiaye MA; Fedorowicz S; Molot A; Ahmad N
    Cancer Lett; 2018 May; 422():9-18. PubMed ID: 29471004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is There a Future for Chemoprevention of Prostate Cancer?
    Bosland MC
    Cancer Prev Res (Phila); 2016 Aug; 9(8):642-7. PubMed ID: 27099271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.
    McCormick DL; Johnson WD; Bosland MC; Lubet RA; Steele VE
    Nutr Cancer; 2007; 57(2):184-93. PubMed ID: 17571952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New opportunities in chemoprevention research.
    Kucuk O
    Cancer Invest; 2002; 20(2):237-45. PubMed ID: 11901544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer chemoprevention: current status and future prospects.
    Gupta S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.